ESN Cleer

ESN Cleer focuses on addressing specific forms of Cardiomyopathy by repurposing drugs for orphan diseases, which lack dedicated treatments. These conditions are significant contributors to heart failure, affecting a wide range of patients with cardiovascular diseases and resulting in high mortality rates and reduced quality of life. In addition to its pharmaceutical efforts, ESN Cleer has developed a handheld medical device that employs nano-sensors on a diagnostic stick to analyze saliva for heart disease biomarkers, predicting the risk of heart disease, heart failure, or heart attack. This device provides users with timely warnings through a dedicated application, further supporting the company's mission to improve outcomes for those at risk of heart-related issues.